Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin alpha 1 as Adjuvant to H1N1 Vaccine in Dialysis Patients
NCT01031966Phase 2Completed
- Sponsor
- Sigma-Tau
- Start
- Nov 2009
- Primary completion
- May 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of thymosin alpha 1 in influenza A H1N1 infection (H1N1), sponsored by Sigma-Tau. Started Nov 2009; status: completed.
02
Drugs
thymosin alpha 1
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT01031966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01031966.